These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 21664904)

  • 1. Multiple signalling pathways underlie the protective effect of levosimendan in cardiac myocytes.
    Markou T; Makridou Z; Galatou E; Lazou A
    Eur J Pharmacol; 2011 Sep; 667(1-3):298-305. PubMed ID: 21664904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levosimendan preserves the contractile responsiveness of hypoxic human myocardium via mitochondrial K(ATP) channel and potential pERK 1/2 activation.
    Soeding PF; Crack PJ; Wright CE; Angus JA; Royse CF
    Eur J Pharmacol; 2011 Mar; 655(1-3):59-66. PubMed ID: 21237146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ERK1/2 and p38 mitogen-activated protein kinase mediate iNOS-induced spinal neuron degeneration after acute traumatic spinal cord injury.
    Xu Z; Wang BR; Wang X; Kuang F; Duan XL; Jiao XY; Ju G
    Life Sci; 2006 Oct; 79(20):1895-905. PubMed ID: 16978658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentiation of a survival signal in the ischemic heart by resveratrol through p38 mitogen-activated protein kinase/mitogen- and stress-activated protein kinase 1/cAMP response element-binding protein signaling.
    Das S; Tosaki A; Bagchi D; Maulik N; Das DK
    J Pharmacol Exp Ther; 2006 Jun; 317(3):980-8. PubMed ID: 16525036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Native and reconstituted HDL activate Stat3 in ventricular cardiomyocytes via ERK1/2: role of sphingosine-1-phosphate.
    Frias MA; James RW; Gerber-Wicht C; Lang U
    Cardiovasc Res; 2009 May; 82(2):313-23. PubMed ID: 19151362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C5a differentially stimulates the ERK1/2 and p38 MAPK phosphorylation through independent signaling pathways to induced chemotactic migration in RAW264.7 macrophages.
    Chiou WF; Tsai HR; Yang LM; Tsai WJ
    Int Immunopharmacol; 2004 Oct; 4(10-11):1329-41. PubMed ID: 15313431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms underlying the activation of L-type calcium channels by urocortin in rat ventricular myocytes.
    Smani T; Calderón-Sanchez E; Gómez-Hurtado N; Fernández-Velasco M; Cachofeiro V; Lahera V; Ordoñez A; Delgado C
    Cardiovasc Res; 2010 Aug; 87(3):459-66. PubMed ID: 20189952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone-releasing hormone promotes survival of cardiac myocytes in vitro and protects against ischaemia-reperfusion injury in rat heart.
    Granata R; Trovato L; Gallo MP; Destefanis S; Settanni F; Scarlatti F; Brero A; Ramella R; Volante M; Isgaard J; Levi R; Papotti M; Alloatti G; Ghigo E
    Cardiovasc Res; 2009 Jul; 83(2):303-12. PubMed ID: 19293247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signalling via the reperfusion injury signalling kinase (RISK) pathway links closure of the mitochondrial permeability transition pore to cardioprotection.
    Davidson SM; Hausenloy D; Duchen MR; Yellon DM
    Int J Biochem Cell Biol; 2006 Mar; 38(3):414-9. PubMed ID: 16280253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p38 mitogen-activated protein kinase (MAPK) is activated by noradrenaline and serves a cardioprotective role, whereas adrenaline induces p38 MAPK dephosphorylation.
    Tsang MY; Rabkin SW
    Clin Exp Pharmacol Physiol; 2009 Aug; 36(8):e12-9. PubMed ID: 19413597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functionally opposing roles of extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase in the regulation of cardiac contractility.
    Szokodi I; Kerkelä R; Kubin AM; Sármán B; Pikkarainen S; Kónyi A; Horváth IG; Papp L; Tóth M; Skoumal R; Ruskoaho H
    Circulation; 2008 Oct; 118(16):1651-8. PubMed ID: 18824646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of p38 mitogen-activated protein kinase abolishes insulin-mediated myocardial protection against ischemia-reperfusion injury.
    Chai W; Wu Y; Li G; Cao W; Yang Z; Liu Z
    Am J Physiol Endocrinol Metab; 2008 Jan; 294(1):E183-9. PubMed ID: 18003719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AMPK activation enhances PPARα activity to inhibit cardiac hypertrophy via ERK1/2 MAPK signaling pathway.
    Meng R; Pei Z; Zhang A; Zhou Y; Cai X; Chen B; Liu G; Mai W; Wei J; Dong Y
    Arch Biochem Biophys; 2011 Jul; 511(1-2):1-7. PubMed ID: 21530483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Propofol post-conditioning protects against cardiomyocyte apoptosis in hypoxia/reoxygenation injury by suppressing nuclear factor-kappa B translocation via extracellular signal-regulated kinase mitogen-activated protein kinase pathway.
    Li H; Tan J; Zou Z; Huang CG; Shi XY
    Eur J Anaesthesiol; 2011 Jul; 28(7):525-34. PubMed ID: 21666544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postconditioning with levosimendan reduces the infarct size involving the PI3K pathway and KATP-channel activation but is independent of PDE-III inhibition.
    Hönisch A; Theuring N; Ebner B; Wagner C; Strasser RH; Weinbrenner C
    Basic Res Cardiol; 2010 Mar; 105(2):155-67. PubMed ID: 19842009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signal transduction pathways through cytoprotective, apoptotic and hypertrophic stimuli: a comparative study in adult cardiac myocytes.
    Markou T; Barlaka E; Bartucci M; Lazou A
    Cell Biochem Funct; 2011 Aug; 29(6):442-51. PubMed ID: 21751224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apelin-13 and apelin-36 exhibit direct cardioprotective activity against ischemia-reperfusion injury.
    Simpkin JC; Yellon DM; Davidson SM; Lim SY; Wynne AM; Smith CC
    Basic Res Cardiol; 2007 Nov; 102(6):518-28. PubMed ID: 17694254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levosimendan induces NO production through p38 MAPK, ERK and Akt in porcine coronary endothelial cells: role for mitochondrial K(ATP) channel.
    Grossini E; Molinari C; Caimmi PP; Uberti F; Vacca G
    Br J Pharmacol; 2009 Jan; 156(2):250-61. PubMed ID: 19154424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin resistance affects the cytoprotective effect of insulin in cardiomyocytes through an impairment of MAPK phosphatase-1 expression.
    Morisco C; Marrone C; Trimarco V; Crispo S; Monti MG; Sadoshima J; Trimarco B
    Cardiovasc Res; 2007 Dec; 76(3):453-64. PubMed ID: 17698050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional down-regulation of thromboxane A(2) receptor expression via activation of MAPK ERK1/2, p38/NF-kappaB pathways.
    Zhang W; Zhang Y; Edvinsson L; Xu CB
    J Vasc Res; 2009; 46(2):162-74. PubMed ID: 18769070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.